share_log

JPMorgan Chase & Co. Decreases Stake in IShares MSCI China A ETF (BATS:CNYA)

JPMorgan Chase & Co. Decreases Stake in IShares MSCI China A ETF (BATS:CNYA)

摩根大通公司減少iShares MSCI中國A股ETF(BATS: CNYA)的股份
Defense World ·  2022/12/05 04:22

JPMorgan Chase & Co. lowered its position in shares of iShares MSCI China A ETF (BATS:CNYA – Get Rating) by 91.9% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 304,129 shares of the company's stock after selling 3,444,934 shares during the quarter. JPMorgan Chase & Co.'s holdings in iShares MSCI China A ETF were worth $11,572,000 as of its most recent filing with the SEC.

摩根大通向美國證券交易委員會提交的最新13F文件顯示,摩根大通在第二季度將其在iShares MSCI中國A股ETF(BATS: CNYA — 獲取評級)的持倉下調了91.9%。該公司在本季度出售了3,444,934股股票後,擁有該公司304,129股股票。摩根大通公司截至最近向美國證券交易委員會提交文件時,其持有的iShares MSCI中國A股ETF價值11,572,000美元。

A number of other institutional investors have also modified their holdings of CNYA. Zions Bancorporation N.A. acquired a new position in iShares MSCI China A ETF during the 1st quarter worth approximately $28,000. Castle Wealth Management LLC acquired a new position in iShares MSCI China A ETF during the 2nd quarter worth approximately $32,000. Envestnet Asset Management Inc. lifted its position in iShares MSCI China A ETF by 21.7% during the 1st quarter. Envestnet Asset Management Inc. now owns 5,644 shares of the company's stock worth $208,000 after acquiring an additional 1,007 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in iShares MSCI China A ETF by 19.1% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 5,967 shares of the company's stock worth $220,000 after acquiring an additional 957 shares in the last quarter. Finally, Vontobel Holding Ltd. acquired a new position in iShares MSCI China A ETF during the 1st quarter worth approximately $267,000.

其他一些機構投資者也修改了他們在CNYA的持股。Zions Bancorporation N.A. 在第一季度收購了iShares MSCI中國A股ETF的新頭寸,價值約28,000美元。Castle Wealth Management LLC在第二季度收購了iShares MSCI中國A股ETF的新頭寸,價值約32,000美元。Envestnet資產管理公司在第一季度將其在iShares MSCI中國A股ETF中的頭寸上調了21.7%。Envestnet資產管理公司在上個季度又收購了1,007股股票後,現在擁有該公司5,644股股票,價值20.8萬美元。雷蒙德·詹姆斯金融服務顧問公司在第一季度將其在iShares MSCI中國A股ETF中的頭寸上調了19.1%。雷蒙德·詹姆斯金融服務顧問公司在上個季度又收購了957股股票後,現在擁有該公司價值22萬美元的5,967股股票。最後,馮託貝爾控股有限公司在第一季度收購了iShares MSCI中國A股ETF的新頭寸,價值約26.7萬美元。

Get
得到
iShares MSCI China A ETF
iShares MSCI 中國 A ETF
alerts:
警報:

iShares MSCI China A ETF Price Performance

iShares MSCI中國A股ETF價格表現

iShares MSCI China A ETF stock opened at $32.30 on Monday. The stock's 50 day moving average price is $30.44 and its 200 day moving average price is $33.42. iShares MSCI China A ETF has a one year low of $25.46 and a one year high of $35.58.

iShares MSCI中國A股ETF股票週一開盤報32.30美元。該股的50天移動平均價格爲30.44美元,其200天移動平均價格爲33.42美元。iShares MSCI中國A股ETF創一年低點25.46美元,一年高點爲35.58美元。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on iShares MSCI China A ETF (CNYA)
  • Is Salesforce Stock a Bargain Down Here?
  • Intel is a Sleeping Giant Ready to Awaken
  • Why CSL Ltd Stock Could Be Worth a Look
  • MarketBeat: Week in Review 11/28 – 12/02
  • Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
  • 免費獲取StockNews.com關於iShares MSCI中國A股ETF(CNYA)的研究報告
  • Salesforce 的股票在這裏便宜嗎?
  • 英特爾是準備覺醒的沉睡巨人
  • 爲什麼 CSL Ltd 的股票值得一看
  • MarketBeat:本週回顧 11/28 — 12/02
  • Okta Inc慶祝盈利突破但他們能否維持增長?

Want to see what other hedge funds are holding CNYA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares MSCI China A ETF (BATS:CNYA – Get Rating).

想看看還有哪些對沖基金持有CNYA嗎?訪問HoldingSchannel.com,獲取iShares MSCI中國A股ETF(BATS: CNYA — 獲取評級)的最新13F申報和內幕交易。

Receive News & Ratings for iShares MSCI China A ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares MSCI China A ETF and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收iShares MSCI中國A股ETF的新聞和評級——在下方輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,獲取iShares MSCI中國A類ETF及相關公司的最新新聞和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論